PhotoMedex Inc  

(Public, NASDAQ:PHMD)   Watch this stock  
Find more results for PHMD
2.29
-0.33 (-12.60%)
Nov 21 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.27 - 2.59
52 week 2.08 - 16.82
Open 2.58
Vol / Avg. 559,183.00/278,438.00
Mkt cap 43.62M
P/E     -
Div/yield     -
EPS -1.05
Shares 19.05M
Beta 0.01
Inst. own 44%
Nov 6, 2014
Q3 2014 PhotoMedex, Inc. Earnings Release
Nov 6, 2014
Q3 2014 PhotoMedex Inc Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -27.83% 8.18%
Operating margin -19.73% 9.81%
EBITD margin - 12.54%
Return on average assets -20.67% 8.51%
Return on average equity -40.63% 11.22%
Employees 168 -
CDP Score - -

Address

SUITE 100, 100 LAKESIDE DRIVE
HORSHAM, PA 19044
United States - Map
+1-215-6193600 (Phone)
+1-215-6193208 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

PhotoMedex, Inc. (PhotoMedex) is a Global Skin Health Solutions company that provides integrated disease management and aesthetic solutions to dermatologists, professional aestheticians and consumers. The Company provides products and services that address skin diseases and conditions including psoriasis, vitiligo, acne, actinic keratosis (a precursor to certain types of skin cancer) and photo damage. PhotoMedex has added a range of home-use devices under the no!no! brand, for various indications including hair removal, acne treatment and skin rejuvenation. The Company also offers a product line for acne clearance, skin tightening, psoriasis care and hair removal sold to physician clinics and spas. The Company operates in three business segments: Consumer segment, Physician Recurring segment and Professional segment. In July 2013, PhotoMedex Inc announced that Radiancy, Inc. acquired LK Technology Importacao E Exportacao LTDA (LK).

Officers and directors

Lewis C. Pell Non-Executive Independent Chairman of the Board of Directors
Age: 71
Bio & Compensation  - Reuters
Dennis M. McGrath President, Chief Financial Officer, Director
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Dolev Rafaeli Chief Executive Officer, Director
Age: 50
Bio & Compensation  - Reuters
Yoav Ben-Dror Non-Executive Independent Vice Chairman of the Board
Age: 61
Bio & Compensation  - Reuters
Trevor S Harris Ph.D. Director
Age: 59
Bio & Compensation  - Reuters
Stephen P. Connelly Independent Director
Age: 62
Bio & Compensation  - Reuters
James W. Sight Independent Director
Age: 58
Bio & Compensation  - Reuters